For citations:
Tsareva AS, Lubennikova EV, Rumyantsev AA, Glazkova EV, Ganshina IP. Experience of using talazoparib in the aggressive course of BRCA2-associated triple-negative breast cancer: a clinical observation. Meditsinskiy sovet = Medical Council. 2023;(11):158-165. (In Russ.) https://doi.org/10.21518/ms2023-247